Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate dose-ranging study for general anesthesia induction in elderly patients
ChiCTR2400083990Phase 4Not yet recruiting
- Sponsor
- Jiaxing Maternity and Child Health Care Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam in anesthesia induction (4 arms), sponsored by Jiaxing Maternity and Child Health Care Hospital. Primary endpoints: Intubation stress reaction and Hemodynamic changes. Planned start May 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
anesthesia induction
Beyond the preview
Go deeper on ChiCTR2400083990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083990.